Table of Content


Chapter 1 Methodology & Scope
1.1 Market definitions
1.2 Base estimates & working
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Digital therapeutics industry 360 degree synopsis, 2018-2032
2.2 Business trends
2.2.1 Component trends
2.2.2 Application trends
2.2.3 Sales channel trends
2.2.4 Regional trends
Chapter 3 Digital Therapeutics Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018-2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing prevalence of chronic diseases
3.3.1.2 Rising need for cost containment
3.3.1.3 Potential to increase quality of care delivery
3.3.1.4 Growing popularity of digital therapeutics
3.3.2 Industry pitfalls & challenges
3.3.2.1 Security and privacy issues
3.3.2.2 Lack of skilled IT professionals
3.4 Growth potential analysis
3.4.1 By component
3.4.2 By application
3.4.3 By sales channel
3.5 COVID-19 impact analysis
3.6 Differences between digital health, digital medicine and digital therapeutics
3.7 Regulatory landscape
3.7.1 U.S.
3.7.2 Europe
3.8 Reimbursement scenario
3.8.1 U.S.
3.8.2 Europe
3.9 Investment overview
3.10 Technology trend analysis
3.11 R&D pipeline for leading digital therapeutics companies
3.12 Digital therapeutics use cases per therapeutic area and example applications
3.13 Impact of digital therapeutics on key stakeholders
3.14 Digital Therapeutics-Biopharma deals, 2019
3.15 Porter’s analysis
3.16 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company matrix analysis, 2021
4.3 Strategy dashboard, 2021
Chapter 5 Digital Therapeutics Market, By Component
5.1 Key segment trends
5.2 Software
5.2.1 Market size, by region, 2018-2032 (USD Million)
5.3 Device
5.3.1 Market size ,by region, 2018-2032 (USD Million)
Chapter 6 Digital Therapeutics Market, By Application
6.1 Key segment trends
6.2 Diabetes
6.2.1 Market size, by region, 2018-2032 (USD Million)
6.3 Obesity
6.3.1 Market size, by region, 2018-2032 (USD Million)
6.4 Cardiovascular
6.4.1 Market size, by region, 2018-2032 (USD Million)
6.5 Mental & behavioral health
6.5.1 Market size, by region, 2018-2032 (USD Million)
6.6 Hypertension
6.6.1 Market size, by region, 2018-2032 (USD Million)
6.7 Insomnia
6.7.1 Market size, by region, 2018-2032 (USD Million)
6.8 Others
6.8.1 Market size, by region, 2018-2032 (USD Million)
Chapter 7 Digital Therapeutics Market, By Sales channel
7.1 Key segment trends
7.2 Business-to-business (B2B)
7.2.1 Market size, by region, 2018-2032 (USD Million)
7.3 Business-to-consumers (B2C)
7.3.1 Market size, by region, 2018-2032 (USD Million)
Chapter 8 Digital Therapeutics Market, By Region
8.1 Key regional trends
8.2 North America
8.2.1 Market size, by country, 2018-2032 (USD Million)
8.2.2 Market size, by component, 2018-2032 (USD Million)
8.2.3 Market size, by application, 2018-2032 (USD Million)
8.2.4 Market size, by sales channel, 2018-2032 (USD Million)
8.2.5 U.S.
8.2.5.1 Market size, by component, 2018-2032 (USD Million)
8.2.5.2 Market size, by application, 2018-2032 (USD Million)
8.2.5.3 Market size, by sales channel, 2018-2032 (USD Million)
8.2.6 Canada
8.2.6.1 Market size, by component, 2018-2032 (USD Million)
8.2.6.2 Market size, by application, 2018-2032 (USD Million)
8.2.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.3 Europe
8.3.1 Market size, by country, 2018-2032 (USD Million)
8.3.2 Market size, by component, 2018-2032 (USD Million)
8.3.3 Market size, by application, 2018-2032 (USD Million)
8.3.4 Market size, by sales channel, 2018-2032 (USD Million)
8.3.5 Germany
8.3.5.1 Market size, by component, 2018-2032 (USD Million)
8.3.5.2 Market size, by application, 2018-2032 (USD Million)
8.3.5.3 Market size, by sales channel, 2018-2032 (USD Million)
8.3.6 UK
8.3.6.1 Market size, by component, 2018-2032 (USD Million)
8.3.6.2 Market size, by application, 2018-2032 (USD Million)
8.3.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.3.7 France
8.3.7.1 Market size, by component, 2018-2032 (USD Million)
8.3.7.2 Market size, by application, 2018-2032 (USD Million)
8.3.7.3 Market size, by sales channel, 2018-2032 (USD Million)
8.3.8 Italy
8.3.8.1 Market size, by component, 2018-2032 (USD Million)
8.3.8.2 Market size, by application, 2018-2032 (USD Million)
8.3.8.3 Market size, by sales channel, 2018-2032 (USD Million)
8.3.9 Spain
8.3.9.1 Market size, by component, 2018-2032 (USD Million)
8.3.9.2 Market size, by application, 2018-2032 (USD Million)
8.3.9.3 Market size, by sales channel, 2018-2032 (USD Million)
8.4 Asia Pacific
8.4.1 Market size, by country, 2018-2032 (USD Million)
8.4.2 Market size, by component, 2018-2032 (USD Million)
8.4.3 Market size, by application, 2018-2032 (USD Million)
8.4.4 Market size, by sales channel, 2018-2032 (USD Million)
8.4.5 Japan
8.4.5.1 Market size, by component, 2018-2032 (USD Million)
8.4.5.2 Market size, by application, 2018-2032 (USD Million)
8.4.5.3 Market size, by sales channel, 2018-2032 (USD Million)
8.4.6 China
8.4.6.1 Market size, by component, 2018-2032 (USD Million)
8.4.6.2 Market size, by application, 2018-2032 (USD Million)
8.4.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.4.7 India
8.4.7.1 Market size, by component, 2018-2032 (USD Million)
8.4.7.2 Market size, by application, 2018-2032 (USD Million)
8.4.7.3 Market size, by sales channel, 2018-2032 (USD Million)
8.4.8 Australia
8.4.8.1 Market size, by component, 2018-2032 (USD Million)
8.4.8.2 Market size, by application, 2018-2032 (USD Million)
8.4.8.3 Market size, by sales channel, 2018-2032 (USD Million)
8.4.9 Singapore
8.4.9.1 Market size, by component, 2018-2032 (USD Million)
8.4.9.2 Market size, by application, 2018-2032 (USD Million)
8.4.9.3 Market size, by sales channel, 2018-2032 (USD Million)
8.5 Latin America
8.5.1 Market size, by country, 2018-2032 (USD Million)
8.5.2 Market size, by component, 2018-2032 (USD Million)
8.5.3 Market size, by application, 2018-2032 (USD Million)
8.5.4 Market size, by sales channel, 2018-2032 (USD Million)
8.5.5 Mexico
8.5.5.1 Market size, by component, 2018-2032 (USD Million)
8.5.5.2 Market size, by application, 2018-2032 (USD Million)
8.5.5.3 Market size, by sales channel, 2018-2032 (USD Million)
8.5.6 Brazil
8.5.6.1 Market size, by component, 2018-2032 (USD Million)
8.5.6.2 Market size, by application, 2018-2032 (USD Million)
8.5.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.6 MEA
8.6.1 Market size, by country, 2018-2032 (USD Million)
8.6.2 Market size, by component, 2018-2032 (USD Million)
8.6.3 Market size, by application, 2018-2032 (USD Million)
8.6.4 Market size, by sales channel, 2018-2032 (USD Million)
8.6.5 Saudi Arabia
8.6.5.1 Market size, by component, 2018-2032 (USD Million)
8.6.5.2 Market size, by application, 2018-2032 (USD Million)
8.6.5.3 Market size, by sales channel, 2018-2032 (USD Million)
8.6.6 South Africa
8.6.6.1 Market size, by component, 2018-2032 (USD Million)
8.6.6.2 Market size, by application, 2018-2032 (USD Million)
8.6.6.3 Market size, by sales channel, 2018-2032 (USD Million)
8.6.7 Israel
8.6.7.1 Market size, by component, 2018-2032 (USD Million)
8.6.7.2 Market size, by application, 2018-2032 (USD Million)
8.6.7.3 Market size, by sales channel, 2018-2032 (USD Million)
Chapter 9 Company Profiles
9.1 Otsuka Holdings Co., Ltd.
9.1.1 Business overview
9.1.2 Financial data
9.1.3 Product landscape
9.1.4 Strategic outlook
9.1.5 SWOT analysis
9.2 Propeller Health (ResMed)
9.2.1 Business overview
9.2.2 Financial data
9.2.3 Product landscape
9.2.4 Strategic outlook
9.2.5 SWOT analysis
9.3 Virta Health Corp
9.3.1 Business overview
9.3.2 Financial data
9.3.3 Product landscape
9.3.4 Strategic outlook
9.3.5 SWOT analysis
9.4 Teladoc Health
9.4.1 Business overview
9.4.2 Financial data
9.4.3 Product landscape
9.4.4 Strategic outlook
9.4.5 SWOT analysis
9.5 Pear Therapeutics Inc
9.5.1 Business overview
9.5.2 Financial data
9.5.3 Product landscape
9.5.4 Strategic outlook
9.5.5 SWOT analysis
9.6 Omada Health Inc
9.6.1 Business overview
9.6.2 Financial data
9.6.3 Product landscape
9.6.4 Strategic outlook
9.6.5 SWOT analysis
9.7 Akili Interactive Labs
9.7.1 Business overview
9.7.2 Financial data
9.7.3 Product landscape
9.7.4 Strategic outlook
9.7.5 SWOT analysis
9.8 WellDoc, Inc.
9.8.1 Business overview
9.8.2 Financial data
9.8.3 Product landscape
9.8.4 Strategic outlook
9.8.5 SWOT analysis
9.9 Click Therapeutics
9.9.1 Business overview
9.9.2 Financial data
9.9.3 Product landscape
9.9.4 Strategic outlook
9.9.5 SWOT analysis
9.10 Biofourmis, Inc.
9.10.1 Business overview
9.10.2 Financial data
9.10.3 Product landscape
9.10.4 Strategic outlook
9.10.5 SWOT analysis
9.11 Lark Health
9.11.1 Business overview
9.11.2 Financial data
9.11.3 Product landscape
9.11.4 Strategic outlook
9.11.5 SWOT analysis
9.12 LifeScan, Inc.
9.12.1 Business overview
9.12.2 Financial data
9.12.3 Product landscape
9.12.4 Strategic outlook
9.12.5 SWOT analysis
9.13 DarioHealth
9.13.1 Business overview
9.13.2 Financial data
9.13.3 Product landscape
9.13.4 Strategic outlook
9.13.5 SWOT analysis
9.14 Voluntis
9.14.1 Business overview
9.14.2 Financial data
9.14.3 Product landscape
9.14.4 Strategic outlook
9.14.5 SWOT analysis
9.15 My Sugr (Roche)
9.15.1 Business overview
9.15.2 Financial data
9.15.3 Product landscape
9.15.4 Strategic outlook
9.15.5 SWOT analysis
 



List of Tables

Data Tables
TABLE 1. Global digital therapeutics market, 2018 - 2024 (USD Million)
TABLE 2. Global digital therapeutics market, 2025 - 2032 (USD Million)
TABLE 3. Global digital therapeutics market, by component, 2018 - 2024 (USD Million)
TABLE 4. Global digital therapeutics market, by component, 2025 - 2032 (USD Million)
TABLE 5. Global digital therapeutics market, by application, 2018 - 2024 (USD Million)
TABLE 6. Global digital therapeutics market, by application, 2025 - 2032 (USD Million)
TABLE 7. Global digital therapeutics market, by sales channels, 2018 - 2024 (USD Million)
TABLE 8. Global digital therapeutics market, by sales channels, 2025 - 2032 (USD Million)
TABLE 9. Global digital therapeutics market, by region, 2018 - 2024 (USD Million)
TABLE 10. Global digital therapeutics market, by region, 2025 - 2032 (USD Million)
TABLE 11. Industry impact forces
TABLE 12. Software market, by region, 2018 - 2024 (USD Million)
TABLE 13. Software market, by region, 2025 - 2032 (USD Million)
TABLE 14. Devices market, by region, 2018 - 2024 (USD Million)
TABLE 15. Devices market, by region, 2025 - 2032 (USD Million)
TABLE 16. Diabetes market, by region, 2018 - 2024 (USD Million)
TABLE 17. Diabetes market, by region, 2025 - 2032 (USD Million)
TABLE 18. Obesity market, by region, 2018 - 2024 (USD Million)
TABLE 19. Obesity market, by region, 2025 - 2032 (USD Million)
TABLE 20. Cardiovascular market, by region, 2018 - 2024 (USD Million)
TABLE 21. Cardiovascular market, by region, 2025 - 2032 (USD Million)
TABLE 22. Mental & behavioral health market, by region, 2018 - 2024 (USD Million)
TABLE 23. Mental & behavioral health market, by region, 2025 - 2032 (USD Million)
TABLE 24. Hypertension market, by region, 2018 - 2024 (USD Million)
TABLE 25. Hypertension market, by region, 2025 - 2032 (USD Million)
TABLE 26. Insomnia market, by region, 2018 - 2024 (USD Million)
TABLE 27. Insomnia market, by region, 2025 - 2032 (USD Million)
TABLE 28. Others market, by region, 2018 - 2024 (USD Million)
TABLE 29. Others market, by region, 2025 - 2032 (USD Million)
TABLE 30. Business-to-business (B2B) market, by region, 2018 - 2024 (USD Million)
TABLE 31. Business-to-business (B2B) market, by region, 2025 - 2032 (USD Million)
TABLE 32. Business-to-consumers (B2C) market, by region, 2018 - 2024 (USD Million)
TABLE 33. Business-to-consumers (B2C) market, by region, 2025 - 2032 (USD Million)
TABLE 34. North America digital therapeutics market, by country, 2018 - 2024, (USD Million)
TABLE 35. North America digital therapeutics market, by country, 2025 - 2032, (USD Million)
TABLE 36. North America digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 37. North America digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 38. North America digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 39. North America digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 40. North America digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 41. North America digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 42. U.S. digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 43. U.S. digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 44. U.S. digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 45. U.S. digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 46. U.S. digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 47. U.S. digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 48. Canada digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 49. Canada digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 50. Canada digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 51. Canada digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 52. Canada digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 53. Canada digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 54. Europe digital therapeutics market, by country, 2018 - 2024, (USD Million)
TABLE 55. Europe digital therapeutics market, by country, 2025 - 2032, (USD Million)
TABLE 56. Europe digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 57. Europe digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 58. Europe digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 59. Europe digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 60. Europe digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 61. Europe digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 62. Germany digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 63. Germany digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 64. Germany digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 65. Germany digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 66. Germany digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 67. Germany digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 68. UK digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 69. UK digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 70. UK digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 71. UK digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 72. UK digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 73. UK digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 74. France digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 75. France digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 76. France digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 77. France digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 78. France digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 79. France digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 80. Italy digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 81. Italy digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 82. Italy digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 83. Italy digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 84. Italy digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 85. Italy digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 86. Spain digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 87. Spain digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 88. Spain digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 89. Spain digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 90. Spain digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 91. Spain digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 92. Asia Pacific digital therapeutics market, by country, 2018 - 2024, (USD Million)
TABLE 93. Asia Pacific digital therapeutics market, by country, 2025 - 2032, (USD Million)
TABLE 94. Asia Pacific digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 95. Asia Pacific digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 96. Asia Pacific digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 97. Asia Pacific digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 98. Asia Pacific digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 99. Asia Pacific digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 100. Japan digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 101. Japan digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 102. Japan digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 103. Japan digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 104. Japan digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 105. Japan digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 106. China digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 107. China digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 108. China digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 109. China digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 110. China digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 111. China digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 112. India digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 113. India digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 114. India digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 115. India digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 116. India digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 117. India digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 118. Australia digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 119. Australia digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 120. Australia digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 121. Australia digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 122. Australia digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 123. Australia digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 124. Singapore digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 125. Singapore digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 126. Singapore digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 127. Singapore digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 128. Singapore digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 129. Singapore digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 130. Latin America digital therapeutics market, by country, 2018 - 2024, (USD Million)
TABLE 131. Latin America digital therapeutics market, by country, 2025 - 2032, (USD Million)
TABLE 132. Latin America digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 133. Latin America digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 134. Latin America digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 135. Latin America digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 136. Latin America digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 137. Latin America digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 138. Brazil digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 139. Brazil digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 140. Brazil digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 141. Brazil digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 142. Brazil digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 143. Brazil digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 144. Mexico digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 145. Mexico digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 146. Mexico digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 147. Mexico digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 148. Mexico digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 149. Mexico digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 150. MEA digital therapeutics market, by country, 2018 - 2024, (USD Million)
TABLE 151. MEA digital therapeutics market, by country, 2025 - 2032, (USD Million)
TABLE 152. MEA digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 153. MEA digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 154. MEA digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 155. MEA digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 156. MEA digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 157. MEA digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 158. Saudi Arabia digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 159. Saudi Arabia digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 160. Saudi Arabia digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 161. Saudi Arabia digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 162. Saudi Arabia digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 163. Saudi Arabia digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 164. South Africa digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 165. South Africa digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 166. South Africa digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 167. South Africa digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 168. South Africa digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 169. South Africa digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
TABLE 170. Israel digital therapeutics market, by component, 2018 - 2024, (USD Million)
TABLE 171. Israel digital therapeutics market, by component, 2025 - 2032, (USD Million)
TABLE 172. Israel digital therapeutics market, by application, 2018 - 2024, (USD Million)
TABLE 173. Israel digital therapeutics market, by application, 2025 - 2032, (USD Million)
TABLE 174. Israel digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
TABLE 175. Israel digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)

Charts & Figures
FIG. 1 Top-down approach
FIG. 2 Breakdown of primary participants
FIG. 3 Digital therapeutics industry 360 degree synopsis, 2018 - 2032
FIG. 4 Industry segmentation
FIG. 5 Industry landscape, 2018 - 2032 (USD Million)
FIG. 6 Growth potential analysis, by component
FIG. 7 Growth potential analysis, by application
FIG. 8 Growth potential analysis, by sales channels
FIG. 9 Impact of digital therapeutics on key stakeholders
FIG. 10 Porter's analysis
FIG. 11 PESTEL analysis
FIG. 12 Company matrix analysis, 2021
FIG. 13 Strategy dashboard, 2021
FIG. 14 Key segment trends, by component
FIG. 15 Key segment trends, by application
FIG. 16 Key segment trends, by sales channels
FIG. 17 Key regional trends